Summary

The global proteomics market is projected to reach USD 65.78 billion by 2030 from USD 36.32 billion in 2025, at a CAGR of 12.6% from 2025 to 2030. Rising use of proteomics in oncology, immunology and other complex diseases is pushing higher routine demand for protein profiling across global labs. Pharma and biotech teams are expanding biomarker programs and running larger translational cohorts, which increases throughput needs for LC-MS workflows, targeted panels, and standardized sample preparation.

https://mnmimg.marketsandmarkets.com/Images/proteomics-market-img-overview.webp

“The immunoassay reagents segment accounted for the largest share by reagent in the proteomics market in 2024”
Based on reagent, the proteomics market is segmented into, protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. The immunoassay reagents dominated the reagent segment; however spectroscopy reagent is anticipated to grow at significant CAGR during the forecast period. Factors like growing use of mass spectrometry-based techniques, development of high-throughput mass spectrometry techniques, increasing interest in personalized medicine and biomarker discovery are likely to drive the segmental growth.
?
“The biopharmaceutical companies segment accounted for the largest share by end user segment in the proteomics market in 2024”
Based on end user, the proteomics market is segmented into hospitals, clinical laboratories, biopharmaceutical companies, academic & research institutes, and other end users. The biopharmaceutical companies segment dominated the proteomics market owing to the rising focus of pharma giants on core activities like increasing R&D for the discovery and development of new molecules.
“The Asia Pacific region is growing at the highest CAGR in the proteomics market from 2025 to 2030.”
Geographically, the proteomics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the proteomics market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as growing fields of proteomics and genomics research in conjunction with an increase in funding toward research studies. Rising investment by biopharmaceutical companies, growing research activity in the area of mAb-based therapeutics are likely to drive market expansion in the region.

The primary interviews conducted for this report can be categorized as follows:

? By Company Type: Tier 1- 40%, Tier 2- 30% and Tier 3- 30%
? By Designation: Directors- 20%, Managers- 10% and Others - 70%,
? By Region: North America -35%, Europe -25%, Asia-Pacific -25%, Latin America -10%, and Middle East -5%.

List of Companies Profiled in the Report:
? Thermo fisher Scientific Inc (US)
? Agilent Technologies, Inc. (US)
? Merck KGaA (Germany)
? Danaher Corporation (US)
? Waters Corporation (US)
? Bio-Rad Laboratories, Inc. (US)
? Bruker Corporation (US)
? Revvity (US)
? Shimadzu Corporation (Japan)
? Illumina Inc (US)
? Promega Corporation (US)
? Eurofins Scientific (Luxembourg)
? Qiagen (Netherlands)
? Charles River Laboratories (US)
? Protagene (Germany)
? Creative Proteomics (US)
? Horiba (Japan)
? Sengenics Corporation LLC (US)
? Labvantage-Biomax GmbH (Germany)
? Cell Signaling Technology, Inc. (US)
? FIOS Genomics (UK)
? Azenta Life Sciences (US)
? Medgenome (India)
? Biognosys AG (Switzerland)
? Macrogen Inc (South Korea)

Research Coverage:
This research report categorizes the proteomics market by Instrumentation Technology : Spectroscopy (Mass spectroscopy, NMR spectroscopy, CD spectroscopy), Chromatography (High performance liquid chromatography, Ion chromatography, Affininty chromatography, Supercritical fluid chromatography), Electrophoresis (Gel electrophoresis, Capillary electrophoresis), Protein Microarrays (Biochips, Microarray instruments), X ray Crystallography, Surface Plasmon Resonance , Protein fractionation, Other intrumentation technologies; by reagent: Immunoassay reagents, spectroscopy reagents, chromatography reagents, protein microarray reagents, X?ray crystallography reagents, electrophoresis reagents, protein fractionation reagents, other reagents; by Service: Core proteomics services (Protein indentification services, Quantitative proteomics services, Protein characterization services, Protein purification services, Protein separation services, Protein sequencing services, Custom assay services), Bioinformatics services; by software: Bioinformatics Tools, Bioinformatics databases; by Application: Clinical Diagnostics (Cancer, Infectious diseases, Diabetes, Neurological disorders, Autoimmune diseases, Cardiovascular diseases, Other clinical diagnostic applications), Drug discovery & Development (Target discovery, Lead identification, Lead optimization, Preclinical studies), Other applications; by End User: Biopharmaceutical Companies, Academic Institutes & Research Institutes, Hospitals, Clinical laboratories, Other end users and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints, influencing the growth of the proteomics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product portfolio, key strategies such as product launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the proteomics market. Competitive analysis of top players and upcoming startups in the proteomics market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall proteomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
Analysis of key drivers (Strong pull from oncology and proteogenomics programs, Growth in multi-omics), restraints (High total cost of ownership), opportunities (Single-cell and low-input proteomics, Cloud and shared data platforms to accelerate discovery), and challenges (Data volume, interpretation and bioinformatics bottlenecks) influencing the growth of the market.
? Product Development/Innovation: Detailed insights on newly launched products and services of the proteomics market
? Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
? Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the proteomics market
? Competitive Assessment: Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Bio?Rad Laboratories (US), Revvity (US), Illumina Inc. (US), Promega Corporation (US) and Charles River Laboratories (US), among others.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 78
1.1 STUDY OBJECTIVES 78
1.2 MARKET DEFINITION 78
1.3 STUDY SCOPE 78
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 79
1.3.2 INCLUSIONS & EXCLUSIONS 80
1.3.3 YEARS CONSIDERED 81
1.3.4 CURRENCY CONSIDERED 81
1.4 STAKEHOLDERS 82
1.5 SUMMARY OF CHANGES 82
2 EXECUTIVE SUMMARY 83
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 83
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 84
2.3 DISRUPTIVE TRENDS IN PROTEOMICS MARKET 85
2.4 HIGH-GROWTH SEGMENTS 86
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 87
3 PREMIUM INSIGHTS 88
3.1 PROTEOMICS MARKET OVERVIEW 88
3.2 NORTH AMERICA: PROTEOMICS MARKET, BY SERVICE 89
3.3 PROTEOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 89
3.4 PROTEOMICS MARKET SHARE, BY APPLICATION, 2026 VS 2031 (%) 90
4 MARKET OVERVIEW 91
4.1 INTRODUCTION 91
4.2 MARKET DYNAMICS 92
4.2.1 DRIVERS 93
4.2.1.1 Advancements in DIA and high-throughput mass spectrometry 93
4.2.1.2 Growing clinical and plasma proteomics adoption for biomarker discovery and translational diagnostics 93
4.2.1.3 Rising integration of proteomics with multi-omics workflows 94
4.2.1.4 Expansion of automation and low-input proteomics workflows 94
4.2.2 RESTRAINTS 94
4.2.2.1 High capital intensity of high-resolution mass spectrometry platforms 94
4.2.2.2 Complexity of proteomics data analysis 95
4.2.3 OPPORTUNITIES 95
4.2.3.1 Emergence of single-cell proteomics for high-resolution cellular profiling 95
4.2.3.2 Expansion of spatial proteomics in tissue-context biology and biomarker research 95
4.2.3.3 Adoption of AI-enabled proteomics informatics 96
4.2.4 CHALLENGES 96
4.2.4.1 Limited detection of low-abundance proteins 96
4.2.4.2 Lack of standardization across workflows 97
4.3 UNMET NEEDS AND WHITE SPACES 97
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 98
4.5 STRATEGIC MOVIES BY TIER-1/2/3 PLAYERS 99
5 INDUSTRY TRENDS 100
5.1 PORTER’S FIVE FORCES ANALYSIS 100
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 101
5.1.2 BARGAINING POWER OF SUPPLIERS 101
5.1.3 BARGAINING POWER OF BUYERS 101
5.1.4 THREAT OF SUBSTITUTES 101
5.1.5 THREAT OF NEW ENTRANTS 101
5.2 MACROECONOMIC OUTLOOK 102
5.2.1 INTRODUCTION 102
5.2.2 GDP TRENDS AND FORECAST 102
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 102
5.2.4 TRENDS IN GLOBAL BIOTECH INDUSTRY 103
5.3 VALUE CHAIN ANALYSIS 104
5.4 ECOSYSTEM ANALYSIS 105
5.4.1 ROLE OF PLAYERS IN ECOSYSTEM 106
5.5 PRICING ANALYSIS 107
5.5.1 AVERAGE SELLING PRICE TREND, KEY PLAYER, 2023-2025 108
5.5.1.1 Instrumentation 108
5.5.1.2 Reagents 109
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023?2025 109
5.5.2.1 Instrumentation 109
5.5.3 REAGENTS 110
5.6 TRADE ANALYSIS 111
5.6.1 IMPORT SCENARIO (HS CODE 9027.20) 111
5.6.2 EXPORT SCENARIO (HS CODE 9027.20) 112
5.6.3 IMPORT SCENARIO (HS CODE 9027.81) 112
5.6.4 EXPORT SCENARIO (HS CODE 9027.81) 113
5.7 KEY CONFERENCES & EVENTS, 2026?2027 114
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 114
5.9 INVESTMENT & FUNDING SCENARIO 115
?
5.10 CASE STUDY ANALYSIS 116
5.10.1 PLASMA PROTEOMICS IMPROVES RISK PREDICTION ACROSS MULTIPLE DISEASES 116
5.10.2 PLASMA PROTEOMICS SUPPORTS ALS BIOMARKER DISCOVERY 116
5.10.3 AI-ENABLED PROTEOMICS ADVANCES DEMENTIA DIAGNOSTICS 117
5.11 IMPACT OF US TARIFF?PROTEOMICS MARKET 117
5.11.1 INTRODUCTION 117
5.11.2 KEY TARIFF RATES 117
5.11.3 PRICE IMPACT ANALYSIS 118
5.11.4 IMPACT ON COUNTRIES/REGIONS 119
5.11.4.1 US 119
5.11.4.2 Europe 119
5.11.4.3 Asia Pacific 120
5.11.5 IMPACT ON END-USE INDUSTRIES 120
5.11.5.1 Hospitals 120
5.11.5.2 Clinical laboratories 120
5.11.5.3 Biopharmaceutical companies 121
5.11.5.4 Academic & research institutes 121
6 SUSTAINABILITY AND REGULATORY LANDSCAPE 122
6.1 REGIONAL REGULATIONS AND COMPLIANCE 122
6.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
6.1.2 INDUSTRY STANDARDS 125
6.1.2.1 North America 125
6.1.2.2 Europe 125
6.1.2.3 Asia Pacific 126
6.1.2.4 Rest of the world 126
6.2 SUSTAINABILITY INITIATIVES 126
6.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 127
6.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 127
7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 129
7.1 KEY TECHNOLOGIES 129
7.1.1 MASS SPECTROMETRY 129
7.1.1.1 Intact/top-down protein analysis 129
7.1.1.2 Chromatography 130
7.1.1.3 Bioinformatics tools 130
7.1.1.4 Protein microarrays 130
?
7.2 COMPLEMENTARY TECHNOLOGIES 131
7.2.1 TRANSCRIPTOMICS 131
7.2.2 METABOLOMICS 131
7.2.3 SINGLE-CELL PROTEOMICS 131
7.3 ADJACENT TECHNOLOGIES 132
7.3.1 AI-DRIVEN PROTEOMICS DATA ANALYSIS 132
7.3.2 AI-DRIVEN PROTEIN STRUCTURE & FUNCTION PREDICTION 132
7.4 TECHNOLOGY ROADMAP 132
7.5 PATENT ANALYSIS 133
7.5.1 METHODOLOGY 133
7.5.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE 133
7.5.3 LIST OF KEY PATENTS 134
7.6 FUTURE APPLICATIONS 135
7.7 IMPACT OF AI/GEN AI ON PROTEOMICS MARKET 136
7.7.1 TOP USE CASES AND MARKET POTENTIAL 137
7.7.2 BEST PRACTICES IN AI-ENABLED PROTEOMICS WORKFLOWS 137
7.7.3 CASE STUDIES OF AI IMPLEMENTATION IN PROTEOMICS MARKET 137
7.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 138
7.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROTEOMICS MARKET 138
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 140
8.1 DECISION-MAKING PROCESS 140
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 140
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 140
8.2.2 KEY BUYING CRITERIA, BY END USER 141
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 142
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 143
9 PROTEOMICS MARKET, BY OFFERING 144
9.1 INTRODUCTION 145
9.2 INSTRUMENTS 145
9.2.1 HIGH-SENSITIVITY AND AUTOMATED PROTEOMICS INSTRUMENT TO DRIVE MARKET GROWTH 145
9.3 REAGENTS & CONSUMABLES 149
9.3.1 SCALABLE MULTIPLEX ASSAYS AND WORKFLOW-READY CONSUMABLES TO DRIVE MARKET 149
9.4 SOFTWARE 152
9.4.1 AI-ENABLED CLOUD-CONNECTED SOFTWARE TO DRIVE MARKET GROWTH 152
9.5 SERVICES 156
9.5.1 OUTSOURCED EXPERTISE AND SCALABLE LC-MS/MS CAPACITY TO DRIVE MARKET 156
?
10 PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES 160
10.1 INTRODUCTION 161
10.2 IMMUNOASSAY REAGENTS & CONSUMABLES 161
10.2.1 ANTIBODIES & HIGH-AFFINITY BINDERS 165
10.2.1.1 Validated high-affinity binders to aid market growth 165
10.2.2 ASSAY KITS 169
10.2.2.1 Prevalidated assay kits to accelerate market growth 169
10.2.3 OTHER IMMUNOASSAY REAGENTS & CONSUMABLES 172
10.3 SPECTROSCOPY REAGENTS & CONSUMABLES 176
10.3.1 MASS TAGGING & LABELING KITS 180
10.3.1.1 Multiplexed protein quantification to aid market growth 180
10.3.2 ENZYMES 183
10.3.2.1 Automation-ready digestion enzymes to drive market growth 183
10.3.3 OTHER SPECTROSCOPY REAGENTS & CONSUMABLES 186
10.4 CHROMATOGRAPHY REAGENTS & CONSUMABLES 189
10.4.1 ANALYTICAL COLUMNS 193
10.4.1.1 High-sensitivity microflow and bio-inert columns to support market growth 193
10.4.2 REAGENTS 196
10.4.2.1 High-purity and method-compatible solvents to support market growth 196
10.4.3 OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES 199
10.5 PROTEIN MICROARRAY REAGENTS & CONSUMABLES 202
10.5.1 BIOCHIPS 206
10.5.1.1 Miniaturized, functionalized biochips to drive market growth 206
10.5.1.2 Lab-on-chips 210
10.5.1.2.1 Integrated microfluidic chips to propel market growth 210
10.5.1.3 Protein chips 213
10.5.1.3.1 Functional protein chips are converting biomarker and interaction discovery into scalable multiplex assays to aid market growth 213
10.5.2 DETECTION REAGENTS 217
10.5.2.1 Brighter, lower-background detection chemistries to propel market growth 217
10.6 X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES 220
10.6.1 CRYSTALLIZATION SCREENS 224
10.6.1.1 Automated high-throughput screening to drive market growth 224
10.6.2 OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES 228
10.7 ELECTROPHORESIS REAGENTS & CONSUMABLES 231
10.7.1 ELECTROPHORESIS STAINS & DYES 235
10.7.1.1 High-sensitivity and MS-compatible stains to improve protein visualization 235
10.7.2 OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES 238
10.8 PROTEIN FRACTIONATION REAGENTS & CONSUMABLES 242
10.8.1 PROTEIN FRACTIONATION & ENRICHMENT KITS 245
10.8.1.1 Automated enrichment kits to drive market growth 245
10.8.2 OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES 249
10.9 OTHER REAGENTS & CONSUMABLES 253
11 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY 257
11.1 INTRODUCTION 258
11.2 SPECTROSCOPY 258
11.2.1 MASS SPECTROMETRY 262
11.2.1.1 High specificity and technological advancements to propel segment growth 262
11.2.2 NMR SPECTROSCOPY 266
11.2.2.1 Accurate evaluation of physical, chemical, electronic, and structural information of proteins to aid segment growth 266
11.2.3 CD SPECTROSCOPY 270
11.2.3.1 Non-destructive and non-invasive techniques to examine changes in secondary protein structures 270
11.3 CHROMATOGRAPHY 273
11.3.1 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 277
11.3.1.1 High resolution, sensitivity, and reproducibility to spur segment growth 277
11.3.2 ION CHROMATOGRAPHY 280
11.3.2.1 High resolving power, simplicity, and controllability to separate and purify proteins 280
11.3.3 AFFINITY CHROMATOGRAPHY 284
11.3.3.1 High specificity for target proteins and easy identification of novel protein interactions to drive segment 284
11.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY 287
11.3.4.1 Ability to separate complex protein mixtures with high efficiency and speed to fuel segment growth 287
11.4 ELECTROPHORESIS 291
11.4.1 GEL ELECTROPHORESIS 295
11.4.1.1 Increasing demand for proteomics research and personalized medicine to boost segment growth 295
11.4.2 CAPILLARY ELECTROPHORESIS 298
11.4.2.1 Low diffusion coefficients of biomolecules and easy elimination of sample carryover between measurements to drive market 298
11.5 PROTEIN MICROARRAYS 302
11.5.1 INTEGRATED SYSTEMS 306
11.5.1.1 Integrated systems to enable high-throughput and reproducible analysis of proteins 306
11.5.2 MICROARRAY SCANNERS 309
11.5.2.1 Cost-effective and high-quality analysis to propel segment growth 309
?
11.5.3 ARRAYERS 313
11.5.3.1 Technological advancements to drive adoption of arrayers in large-scale projects 313
11.6 X-RAY CRYSTALLOGRAPHY 316
11.6.1 RISING NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES TO AUGMENT MARKET GROWTH 316
11.7 SURFACE PLASMON RESONANCE 319
11.7.1 INCREASING ABILITY TO BIND AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET GROWTH 319
11.8 PROTEIN FRACTIONATION 323
11.8.1 PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF PROTEINS IN COMPLEX MIXTURES 323
11.9 OTHER INSTRUMENTATION TECHNOLOGIES 326
12 PROTEOMICS MARKET, BY SERVICE 330
12.1 INTRODUCTION 331
12.2 CORE PROTEOMICS SERVICES 331
12.2.1 PROTEIN IDENTIFICATION SERVICES 335
12.2.1.1 Outsourced mass spectrometry and complex-sample workflows to boost market growth 335
12.2.2 QUANTITATIVE PROTEOMICS SERVICES 339
12.2.2.1 Quantified protein profiling and translational model validation to drive market growth 339
12.2.3 PROTEIN CHARACTERIZATION SERVICES 342
12.2.3.1 Biologics complexity and comparability testing to drive market growth 342
12.2.4 PROTEIN PURIFICATION SERVICES 346
12.2.4.1 High-purity biologics and outsourced purification expertise to drive market 346
12.2.5 PROTEIN SEPARATION SERVICES 349
12.2.5.1 Complex sample analysis and biomarker research to augment segment growth 349
12.2.6 PROTEIN SEQUENCING SERVICES 353
12.2.6.1 Antibody development and outsourced sequence interpretation to drive market 353
12.2.7 CUSTOM ASSAY SERVICES 356
12.2.7.1 Biomarker specificity and outsourced assay design to drive market 356
12.3 BIOINFORMATICS SERVICES 360
12.3.1 SCALABLE DATA INTERPRETATION AND MULTI-OMICS INTEGRATION TO SPUR MARKET GROWTH 360
?
13 PROTEOMICS MARKET, BY SOFTWARE 364
13.1 INTRODUCTION 365
13.2 BIOINFORMATICS TOOLS 365
13.2.1 RISING DATA COMPLEXITY AND AI-ENABLED ANALYSIS TO AUGMENT MARKET GROWTH 365
13.3 BIOINFORMATICS DATABASES 369
13.3.1 EXPANDING CURATED PROTEIN KNOWLEDGEBASES AND MULTI-OMICS INTEGRATION TO DRIVE MARKET 369
14 PROTEOMICS MARKET, BY WORKFLOW 373
14.1 INTRODUCTION 374
14.2 SAMPLE PREPARATION 374
14.2.1 AUTOMATION, REPRODUCIBILITY, AND HIGH-THROUGHPUT BIOMARKER WORKFLOWS TO AUGMENT MARKET GROWTH 374
14.3 PROTEIN SEPARATION & FRACTIONATION 378
14.3.1 RISING DEMAND FOR DEEPER PROTEOME COVERAGE AND IMPROVED LC-MS SENSITIVITY TO DRIVE MARKET 378
14.4 PROTEIN IDENTIFICATION & QUANTIFICATION 381
14.4.1 HIGHER SENSITIVITY, DEEPER PROTEOME COVERAGE, AND SCALABLE QUANTIFICATION WORKFLOWS TO AUGMENT MARKET GROWTH 381
14.5 PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS 385
14.5.1 RISING BIOLOGICS COMPLEXITY AND DEMAND FOR STRUCTURE-FUNCTION INSIGHTS TO DRIVE MARKET 385
14.6 BIOINFORMATICS & DATA ANALYSIS 388
14.6.1 RISING DATA COMPLEXITY, DIA ADOPTION, AND AI-ENABLED INTERPRETATION TO DRIVE MARKET 388
15 PROTEOMICS MARKET, BY TYPE 392
15.1 INTRODUCTION 393
15.1.1 BULK PROTEOMICS 393
15.1.1.1 Large-cohort biomarker discovery, high-throughput protein profiling, and scalable multi-omics integration to drive market growth 393
15.1.2 TARGETED/AFFINITY PROTEOMICS 397
15.1.2.1 High-sensitivity protein panels and scalable biomarker validation to drive the market 397
15.1.3 SPATIAL PROTEOMICS 400
15.1.3.1 Emerging spatial biology workflows to drive market growth 400
15.1.4 SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS 404
15.1.4.1 Demand for ultra-sensitive and low-input protein analysis to drive market 404
?
16 PROTEOMICS MARKET, BY APPLICATION 408
16.1 INTRODUCTION 409
16.2 CLINICAL DIAGNOSTICS 409
16.2.1 CANCER 413
16.2.1.1 Precision oncology and high-sensitivity protein biomarker testing to propel market growth 413
16.2.2 INFECTIOUS DISEASES 417
16.2.2.1 Rapid pathogen identification to support market growth 417
16.2.3 DIABETES 420
16.2.3.1 Precision diabetes care and protein-based risk stratification to aid market growth 420
16.2.4 NEUROLOGICAL DISORDERS 424
16.2.4.1 Blood-based neuroprotein biomarkers to fuel market growth 424
16.2.5 AUTOIMMUNE DISEASES 427
16.2.5.1 Demand for immune-pathway biomarkers and flare monitoring to propel market growth 427
16.2.6 CARDIOVASCULAR DISEASES 431
16.2.6.1 Multi-protein cardiovascular risk profiling to drive growth 431
16.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS 434
16.3 DRUG DISCOVERY & DEVELOPMENT 438
16.3.1 TARGET DISCOVERY 442
16.3.1.1 High-throughput proteomics and AI-enabled target biology to support segment growth 442
16.3.2 LEAD IDENTIFICATION 445
16.3.2.1 Chemoproteomics and high-throughput protein profiling to propel growth 445
16.3.3 LEAD OPTIMIZATION 449
16.3.3.1 Need for optimizing drug efficacy and safety to spur segment growth 449
16.3.4 PRECLINICAL STUDIES 452
16.3.4.1 Translational safety biomarkers and pathway-level efficacy assessment to drive growth 452
16.4 OTHER APPLICATIONS 456
17 PROTEOMICS MARKET, BY END USER 460
17.1 INTRODUCTION 461
17.2 BIOPHARMACEUTICAL COMPANIES 461
17.2.1 PRECISION MEDICINE, BIOMARKER-LED R&D, AND POPULATION-SCALE PROTEOMICS TO DRIVE MARKET 461
17.3 ACADEMIC & RESEARCH INSTITUTES 465
17.3.1 SHARED CORE INFRASTRUCTURE AND MULTI-OMICS RESEARCH MEDICINE TO BOOST MARKET GROWTH 465
17.4 HOSPITALS 468
17.4.1 PRECISION DIAGNOSTICS AND HOSPITAL-BASED TRANSLATIONAL RESEARCH TO BOOST MARKET GROWTH 468
17.5 CLINICAL LABORATORIES 472
17.5.1 PROTEIN-BASED DIAGNOSTICS AND LABORATORY WORKFLOW AUTOMATION TO SUPPORT MARKET GROWTH 472
17.6 OTHER END USERS 475
18 PROTEOMICS MARKET, BY REGION 479
18.1 INTRODUCTION 480
18.2 NORTH AMERICA 480
18.2.1 US 492
18.2.1.1 Precision medicine, high-throughput platforms, and biomarker-driven drug development to drive the market growth. 492
18.2.2 CANADA 503
18.2.2.1 Precision oncology networks, standardized LC-MS workflows, and AI-enabled multiomics to drive the market growth 503
18.3 EUROPE 514
18.3.1 GERMANY 525
18.3.1.1 Well-established pharmaceutical industry and increased government funding to augment market growth 525
18.3.2 UK 536
18.3.2.1 Population biobanks, clinical cohorts, and high-throughput multiomics to drive market growth 536
18.3.3 FRANCE 547
18.3.3.1 National infrastructure, clinical biomarker programs, and multiomics collaboration to drive the market growth 547
18.3.4 SWITZERLAND 558
18.3.4.1 Pharma-led innovation, deep plasma proteomics, and translational multiomics to drive the market growth 558
18.3.5 ITALY 569
18.3.5.1 Clinical multiomics, biomarker research, and cross-border proteomics collaboration to drive the market growth 569
18.3.6 SPAIN 580
18.3.6.1 Spatial omics infrastructure, clinical collaboration, and high-throughput proteomics to drive the market growth 580
18.3.7 REST OF EUROPE 591
18.4 ASIA PACIFIC 602
18.4.1 CHINA 614
18.4.1.1 Precision medicine investment, automated LC-MS/MS workflows, and large-scale clinical proteomics to fuel market growth 614
18.4.2 JAPAN 625
18.4.2.1 Precision medicine, automated LC-MS/MS workflows, and clinical biomarker programs to drive market 625
18.4.3 INDIA 636
18.4.3.1 Biopharma R&D and LC-MS/MS adoption to support market growth 636
18.4.4 SOUTH KOREA 647
18.4.4.1 Biopharma innovation, high-plex protein profiling, and automated multiomics workflows to propel market growth 647
18.4.5 AUSTRALIA 658
18.4.5.1 Translational biomedicine, high-resolution LC-MS/MS, and automated protein analytics to favor market growth 658
18.4.6 REST OF ASIA PACIFIC 669
18.5 LATIN AMERICA 679
18.5.1 BRAZIL 690
18.5.1.1 Open LC-MS/MS infrastructure and translational biomarker programs to drive market 690
18.5.2 MEXICO 701
18.5.2.1 Oncology biomarker research to augment market growth 701
18.5.3 REST OF LATIN AMERICA 712
18.6 MIDDLE EAST 723
18.6.1 GCC COUNTRIES 734
18.6.1.1 Saudi Arabia 745
18.6.1.1.1 Biotechnology localization and clinical biomarker research to boost market growth 745
18.6.1.2 UAE 756
18.6.1.2.1 Multiomics infrastructure and public-private research partnerships to drive market 756
18.6.1.3 Rest of GCC Countries 767
18.6.2 REST OF MIDDLE EAST 778
18.7 AFRICA 789
18.7.1 BIOMARKER PLATFORM ADOPTION TO PROPEL MARKET GROWTH 789
19 COMPETITIVE LANDSCAPE 801
19.1 INTRODUCTION 801
19.2 KEY PLAYER STRATEGY/RIGHT TO WIN, 2021?2025 801
19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEOMICS MARKET, JANUARY 2023-APRIL 2026 801
19.3 REVENUE ANALYSIS, 2021?2025 803
19.4 MARKET SHARE ANALYSIS, 2025 804
19.5 BRAND COMPARISON 807
19.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 808
19.6.1 STARS 808
19.6.2 EMERGING LEADERS 808
19.6.3 PERVASIVE PLAYERS 808
19.6.4 PARTICIPANTS 808
19.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 810
19.6.5.1 Company footprint 810
19.6.5.2 Region footprint 811
19.6.5.3 Instrumentation technology footprint 812
19.6.5.4 Reagent footprint 813
19.6.5.5 Service footprint 815
19.6.5.6 Software footprint 816
19.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 817
19.7.1 PROGRESSIVE COMPANIES 817
19.7.2 RESPONSIVE COMPANIES 817
19.7.3 DYNAMIC COMPANIES 817
19.7.4 STARTING BLOCKS 817
19.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 819
19.7.5.1 Detailed list of key startup/SME players 819
19.7.5.2 Competitive benchmarking of startups/SMEs 820
19.8 COMPANY VALUATION AND FINANCIAL METRICS 821
19.8.1 COMPANY VALUATION 821
19.8.2 FINANCIAL METRICS 822
19.9 COMPETITIVE SCENARIO 822
19.9.1 PRODUCT LAUNCHES 822
19.9.2 DEALS 823
19.9.3 EXPANSIONS 824
20 COMPANY PROFILES 825
20.1 KEY PLAYERS 825
20.1.1 THERMO FISHER SCIENTIFIC INC. 825
20.1.1.1 Business overview 825
20.1.1.2 Products/Services/Solutions offered 826
20.1.1.3 Recent developments 839
20.1.1.3.1 Product launches 839
20.1.1.3.2 Deals 840
20.1.1.4 MnM view 840
20.1.1.4.1 Key strengths 840
20.1.1.4.2 Strategic choices 840
20.1.1.4.3 Weaknesses and competitive threats 840
20.1.2 AGILENT TECHNOLOGIES, INC. 841
20.1.2.1 Business overview 841
20.1.2.2 Products/Services/Solutions offered 842
20.1.2.3 Recent developments 847
20.1.2.3.1 Product launches 847
20.1.2.3.2 Deals 848
20.1.2.3.3 Expansions 849
20.1.2.4 MnM view 849
20.1.2.4.1 Key strengths 849
20.1.2.4.2 Strategic choices 849
20.1.2.4.3 Weaknesses and competitive threats 849
?
20.1.3 MERCK KGAA 850
20.1.3.1 Business overview 850
20.1.3.2 Products/Services/Solutions offered 851
20.1.3.3 Recent developments 854
20.1.3.3.1 Deals 854
20.1.3.4 MnM view 854
20.1.3.4.1 Key strengths 854
20.1.3.4.2 Strategic choices 854
20.1.3.4.3 Weaknesses and competitive threats 854
20.1.4 DANAHER CORPORATION 855
20.1.4.1 Business overview 855
20.1.4.2 Products/Services/Solutions offered 856
20.1.4.3 Recent developments 868
20.1.4.3.1 Product launches 868
20.1.4.3.2 Deals 869
20.1.4.4 MnM view 869
20.1.4.4.1 Key strengths 869
20.1.4.4.2 Strategic choices 869
20.1.4.4.3 Weaknesses and competitive threats 869
20.1.5 SHIMADZU CORPORATION 870
20.1.5.1 Business overview 870
20.1.5.2 Products/Services/Solutions offered 871
20.1.5.3 Recent developments 876
20.1.5.3.1 Product launches 876
20.1.5.3.2 Expansions 876
20.1.5.4 MnM view 877
20.1.5.4.1 Key strengths 877
20.1.5.4.2 Strategic choices 877
20.1.5.4.3 Weaknesses and competitive threats 877
20.1.6 WATERS CORPORATION 878
20.1.6.1 Business overview 878
20.1.6.2 Products/Services/Solutions offered 879
20.1.6.3 Recent developments 886
20.1.6.3.1 Product launches 886
20.1.6.3.2 Deals 886
20.1.7 BIO-RAD LABORATORIES, INC. 887
20.1.7.1 Business overview 887
20.1.7.2 Products/Services/Solutions offered 888
?
20.1.8 BRUKER 897
20.1.8.1 Business overview 897
20.1.8.2 Products/Services/Solutions offered 898
20.1.8.3 Recent developments 904
20.1.8.3.1 Product launches 904
20.1.8.3.2 Deals 905
20.1.9 REVVITY 906
20.1.9.1 Business overview 906
20.1.9.2 Products/Services/Solutions offered 907
20.1.9.3 Recent developments 910
20.1.9.3.1 Product launches 910
20.1.10 ILLUMINA, INC. 911
20.1.10.1 Business overview 911
20.1.10.2 Products/Services/Solutions offered 912
20.1.10.3 Recent developments 914
20.1.10.3.1 Deals 914
20.1.11 PROMEGA CORPORATION 915
20.1.11.1 Business overview 915
20.1.11.2 Products/Services/Solutions offered 915
20.1.12 EUROFINS SCIENTIFIC 919
20.1.12.1 Business overview 919
20.1.12.2 Products/Services/Solutions offered 920
20.1.12.3 Recent developments 921
20.1.12.3.1 Deals 921
20.1.13 QIAGEN 922
20.1.13.1 Business overview 922
20.1.13.2 Products/Services/Solutions offered 923
20.1.13.3 Recent developments 926
20.1.13.3.1 Product launches 926
20.1.13.3.2 Deals 927
20.1.14 CHARLES RIVER LABORATORIES 928
20.1.14.1 Business overview 928
20.1.14.2 Products/Services/Solutions offered 929
20.1.14.3 Recent developments 931
20.1.14.3.1 Product launches 931
20.1.14.3.2 Deals 932
20.1.15 PROTAGENE 933
20.1.15.1 Business overview 933
20.1.15.2 Products/Services/Solutions offered 933
20.1.16 BIO-TECHNE 936
20.1.16.1 Business overview 936
20.1.16.2 Products/Services/Solutions offered 937
20.1.17 AZENTA US INC. 939
20.1.17.1 Business overview 939
20.1.17.2 Products/Services/Solutions offered 940
20.1.18 QUANTERIX 941
20.1.18.1 Business overview 941
20.1.18.2 Products/Services/Solutions offered 942
20.1.19 PROTEOMICS INTERNATIONAL 943
20.1.19.1 Business overview 943
20.1.19.2 Products/Services/Solutions offered 944
20.1.20 HAMILTON COMPANY 945
20.1.20.1 Business overview 945
20.1.20.2 Products/Services/Solutions offered 945
20.1.20.3 Recent developments 946
20.1.20.3.1 Product launches 946
20.2 OTHER PLAYERS 947
20.2.1 CREATIVE PROTEOMICS 947
20.2.2 HORIBA, LTD. 949
20.2.3 LABVANTAGE-BIOMAX GMBH 950
20.2.4 FIOS GENOMICS 951
20.2.5 MEDGENOME 952
20.2.6 BIOGNOSYS AG 953
20.2.7 MACROGEN, INC. 954
20.2.8 CELL SIGNALING TECHNOLOGY, INC. 955
20.2.9 STANDARD BIOTOOLS 956
20.2.10 PIXELGEN TECHNOLOGIES 957
20.2.11 APPLIED BIOMICS 957
20.2.12 QUANTUM-SI INCORPORATED 958
20.2.13 ERISYON INC. 959
20.2.14 NAUTILUS BIOTECHNOLOGY, INC. 960
21 RESEARCH METHODOLOGY 961
21.1 RESEARCH DATA 961
21.1.1 SECONDARY DATA 961
21.1.1.1 Key data from secondary sources 961
21.1.2 PRIMARY DATA 962
21.1.2.1 Key data from primary sources 962
21.1.2.2 Key primary participants 963
21.1.2.3 Breakdown of primary interviews 963
21.1.2.4 Key industry insights 964
21.2 MARKET SIZE ESTIMATION 965
21.2.1 GLOBAL PROTEOMICS MARKET ESTIMATION, 2025 965
21.2.2 SEGMENTAL MARKET SIZE ESTIMATION 967
21.3 MARKET GROWTH RATE PROJECTIONS 969
21.4 DATA TRIANGULATION 971
21.5 FACTOR ANALYSIS 972
21.6 RESEARCH ASSUMPTIONS 972
21.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT 973
22 APPENDIX 974
22.1 DISCUSSION GUIDE 974
22.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 979
22.3 CUSTOMIZATION OPTIONS 981
22.4 RELATED REPORTS 981
22.5 AUTHOR DETAILS 982

ページTOPに戻る

List of Tables/Graphs

TABLE 1 PROTEOMICS MARKET: INCLUSIONS AND EXCLUSIONS 80
TABLE 2 PROTEOMICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 92
TABLE 3 PROTEOMICS MARKET: PORTER’S FIVE FORCES 100
TABLE 4 PROTEOMICS MARKET: ROLE OF PLAYERS IN ECOSYSTEM 106
TABLE 5 AVERAGE SELLING PRICE TREND OF INSTRUMENTATION, BY KEY PLAYER,
2023?2025 (USD) 108
TABLE 6 AVERAGE SELLING PRICE TREND OF REAGENTS, BY KEY PLAYER,
2023-2025 (USD) 109
TABLE 7 AVERAGE SELLING PRICE TREND OF INSTRUMENTATION, BY REGION,
2023?2025 (USD) 109
TABLE 8 AVERAGE SELLING PRICE TREND OF REAGENTS, BY REGION, 2023?2025 (USD) 110
TABLE 9 IMPORT DATA FOR HS CODE 9027.20-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (USD THOUSAND) 111
TABLE 10 EXPORT DATA FOR HS CODE 9027.20-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (USD THOUSAND) 112
TABLE 11 IMPORT DATA FOR HS CODE 9027.81-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (USD THOUSAND) 112
TABLE 12 EXPORT DATA FOR HS CODE 9027.81-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (USD THOUSAND) 113
TABLE 13 PROTEOMICS MARKET: LIST OF KEY CONFERENCES & EVENTS,
JANUARY 2026?MARCH 2027 114
TABLE 14 RECIPROCAL TARIFF RATES ADJUSTED BY US 117
TABLE 15 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 119
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 124
TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 124
TABLE 20 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015?2025 133
TABLE 21 LIST OF KEY PATENTS IN THE PROTEOMICS MARKET, 2023-2025 134
TABLE 22 CASE STUDIES OF AI IMPLEMENTATION IN PROTEOMICS MARKET 137
TABLE 23 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROTEOMICS MARKET 138
TABLE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 141
TABLE 25 KEY BUYING CRITERIA, BY END USER 141
TABLE 26 PROTEOMICS MARKET, BY OFFERING, 2024?2031 (USD MILLION) 145
TABLE 27 PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2024?2031 (USD MILLION) 146
TABLE 28 NORTH AMERICA: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 146
TABLE 29 EUROPE: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 147
TABLE 30 ASIA PACIFIC: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 147
TABLE 31 LATIN AMERICA: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 148
TABLE 32 MIDDLE EAST: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 148
TABLE 33 GCC COUNTRIES: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 148
TABLE 34 PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY REGION,
2024?2031 (USD MILLION) 149
TABLE 35 NORTH AMERICA: PROTEOMICS REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 150
TABLE 36 EUROPE: PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 150
TABLE 37 ASIA PACIFIC: PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 151
TABLE 38 LATIN AMERICA: PROTEOMICS REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 151
TABLE 39 MIDDLE EAST: PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 152
TABLE 40 GCC COUNTRIES: PROTEOMICS REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 152
TABLE 41 PROTEOMICS SOFTWARE MARKET, BY REGION, 2024?2031 (USD MILLION) 153
TABLE 42 NORTH AMERICA: PROTEOMICS SOFTWARE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 153
TABLE 43 EUROPE: PROTEOMICS SOFTWARE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 154
TABLE 44 ASIA PACIFIC: PROTEOMICS SOFTWARE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 154
TABLE 45 LATIN AMERICA: PROTEOMICS SOFTWARE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 155
TABLE 46 MIDDLE EAST: PROTEOMICS SOFTWARE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 155
TABLE 47 GCC COUNTRIES: PROTEOMICS SOFTWARE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 155
TABLE 48 PROTEOMICS SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 156
TABLE 49 NORTH AMERICA: PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 157
TABLE 50 EUROPE: PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 157
TABLE 51 ASIA PACIFIC: PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 158
TABLE 52 LATIN AMERICA: PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 158
TABLE 53 MIDDLE EAST: PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 158
TABLE 54 GCC COUNTRIES: PROTEOMICS SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 159
TABLE 55 PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES,
2024?2031 (USD MILLION) 161
TABLE 56 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES,
BY TYPE, 2024?2031 (USD MILLION) 162
TABLE 57 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES,
BY REGION, 2024?2031 (USD MILLION) 162
TABLE 58 NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 163
TABLE 59 EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 163
TABLE 60 ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 164
TABLE 61 LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 164
TABLE 62 MIDDLE EAST: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 165
TABLE 63 GCC COUNTRIES: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 165
TABLE 64 IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY REGION, 2024?2031 (USD MILLION) 166
TABLE 65 NORTH AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024?2031 (USD MILLION) 166
TABLE 66 EUROPE: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024?2031 (USD MILLION) 167
TABLE 67 ASIA PACIFIC: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024?2031 (USD MILLION) 167
TABLE 68 LATIN AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024?2031 (USD MILLION) 168
TABLE 69 MIDDLE EAST: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024?2031 (USD MILLION) 168
TABLE 70 GCC COUNTRIES: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024?2031 (USD MILLION) 168
TABLE 71 IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2024?2031 (USD MILLION) 169
TABLE 72 NORTH AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024?2031 (USD MILLION) 170
TABLE 73 EUROPE: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024?2031 (USD MILLION) 170
TABLE 74 ASIA PACIFIC: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024?2031 (USD MILLION) 171
TABLE 75 LATIN AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024?2031 (USD MILLION) 171
TABLE 76 MIDDLE EAST: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024?2031 (USD MILLION) 171
TABLE 77 GCC COUNTRIES: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024?2031 (USD MILLION) 172
TABLE 78 IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY REGION, 2024?2031 (USD MILLION) 173
TABLE 79 NORTH AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY,
2024?2031 (USD MILLION) 173
TABLE 80 EUROPE: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY,
2024?2031 (USD MILLION) 174
TABLE 81 ASIA PACIFIC: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY,
2024?2031 (USD MILLION) 174
TABLE 82 LATIN AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY,
2024?2031 (USD MILLION) 175
TABLE 83 MIDDLE EAST: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY,
2024?2031 (USD MILLION) 175
TABLE 84 GCC COUNTRIES: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY,
2024?2031 (USD MILLION) 175
TABLE 85 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES,
BY TYPE, 2024?2031 (USD MILLION) 176
TABLE 86 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES,
BY REGION, 2024?2031 (USD MILLION) 177
TABLE 87 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 177
TABLE 88 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 178
TABLE 89 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 178
TABLE 90 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 179
TABLE 91 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 179
TABLE 92 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 179
TABLE 93 SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY REGION, 2024?2031 (USD MILLION) 180
TABLE 94 NORTH AMERICA: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024?2031 (USD MILLION) 180
TABLE 95 EUROPE: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024?2031 (USD MILLION) 181
TABLE 96 ASIA PACIFIC: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024?2031 (USD MILLION) 181
TABLE 97 LATIN AMERICA: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024?2031 (USD MILLION) 182
TABLE 98 MIDDLE EAST: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024?2031 (USD MILLION) 182
TABLE 99 GCC COUNTRIES: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024?2031 (USD MILLION) 182
TABLE 100 SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY REGION, 2024?2031 (USD MILLION) 183
TABLE 101 NORTH AMERICA: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024?2031 (USD MILLION) 183
TABLE 102 EUROPE: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024?2031 (USD MILLION) 184
TABLE 103 ASIA PACIFIC: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024?2031 (USD MILLION) 184
TABLE 104 LATIN AMERICA: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024?2031 (USD MILLION) 185
TABLE 105 MIDDLE EAST: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024?2031 (USD MILLION) 185
TABLE 106 GCC COUNTRIES: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024?2031 (USD MILLION) 185
TABLE 107 OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY REGION, 2024?2031 (USD MILLION) 186
TABLE 108 NORTH AMERICA: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 186
TABLE 109 EUROPE: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 187
TABLE 110 ASIA PACIFIC: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 187
TABLE 111 LATIN AMERICA: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 188
TABLE 112 MIDDLE EAST: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 188
TABLE 113 GCC COUNTRIES: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 188
TABLE 114 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES,
BY TYPE, 2024?2031 (USD MILLION) 189
TABLE 115 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES,
BY REGION, 2024?2031 (USD MILLION) 190
TABLE 116 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 190
TABLE 117 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 191
TABLE 118 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 191
TABLE 119 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 192
TABLE 120 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 192
TABLE 121 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 192
TABLE 122 CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY REGION, 2024?2031 (USD MILLION) 193
TABLE 123 NORTH AMERICA: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024?2031 (USD MILLION) 193
TABLE 124 EUROPE: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024?2031 (USD MILLION) 194
TABLE 125 ASIA PACIFIC: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024?2031 (USD MILLION) 194
TABLE 126 LATIN AMERICA: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024?2031 (USD MILLION) 195
TABLE 127 MIDDLE EAST: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024?2031 (USD MILLION) 195
TABLE 128 GCC COUNTRIES: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024?2031 (USD MILLION) 195
TABLE 129 CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2024?2031 (USD MILLION) 196
TABLE 130 NORTH AMERICA: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024?2031 (USD MILLION) 196
TABLE 131 EUROPE: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024?2031 (USD MILLION) 197
TABLE 132 ASIA PACIFIC: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024?2031 (USD MILLION) 197
TABLE 133 LATIN AMERICA: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024?2031 (USD MILLION) 198
TABLE 134 MIDDLE EAST: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024?2031 (USD MILLION) 198
TABLE 135 GCC COUNTRIES: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024?2031 (USD MILLION) 198
TABLE 136 OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY REGION, 2024?2031 (USD MILLION) 199
TABLE 137 NORTH AMERICA: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 199
TABLE 138 EUROPE: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 200
TABLE 139 ASIA PACIFIC: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 200
TABLE 140 LATIN AMERICA: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 201
TABLE 141 MIDDLE EAST: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 201
TABLE 142 GCC COUNTRIES: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 201
TABLE 143 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024?2031 (USD MILLION) 202
TABLE 144 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY REGION, 2024?2031 (USD MILLION) 203
TABLE 145 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 203
TABLE 146 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 204
TABLE 147 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 204
TABLE 148 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 205
TABLE 149 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 205
TABLE 150 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 205
TABLE 151 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY TYPE, 2024?2031 (USD MILLION) 206
TABLE 152 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY REGION, 2024?2031 (USD MILLION) 207
TABLE 153 NORTH AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 207
TABLE 154 EUROPE: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 208
TABLE 155 ASIA PACIFIC: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 208
TABLE 156 LATIN AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 209
TABLE 157 MIDDLE EAST: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 209
TABLE 158 GCC COUNTRIES: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 209
TABLE 159 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY REGION, 2024?2031 (USD MILLION) 210
TABLE 160 NORTH AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 211
TABLE 161 EUROPE: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 211
TABLE 162 ASIA PACIFIC: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 212
TABLE 163 LATIN AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 212
TABLE 164 MIDDLE EAST: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 213
TABLE 165 GCC COUNTRIES: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 213
TABLE 166 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY REGION, 2024?2031 (USD MILLION) 214
TABLE 167 NORTH AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 214
TABLE 168 EUROPE: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 215
TABLE 169 ASIA PACIFIC: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 215
TABLE 170 LATIN AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 216
TABLE 171 MIDDLE EAST: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 216
TABLE 172 GCC COUNTRIES: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024?2031 (USD MILLION) 216
TABLE 173 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY REGION, 2024?2031 (USD MILLION) 217
TABLE 174 NORTH AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024?2031 (USD MILLION) 218
TABLE 175 EUROPE: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024?2031 (USD MILLION) 218
TABLE 176 ASIA PACIFIC: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024?2031 (USD MILLION) 219
TABLE 177 LATIN AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024?2031 (USD MILLION) 219
TABLE 178 MIDDLE EAST: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024?2031 (USD MILLION) 220
TABLE 179 GCC COUNTRIES: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024?2031 (USD MILLION) 220
TABLE 180 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024?2031 (USD MILLION) 221
TABLE 181 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY REGION, 2024?2031 (USD MILLION) 221
TABLE 182 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 222
TABLE 183 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 222
TABLE 184 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 223
TABLE 185 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 223
TABLE 186 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 223
TABLE 187 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 224
TABLE 188 X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY REGION, 2024?2031 (USD MILLION) 225
TABLE 189 NORTH AMERICA: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY,
2024?2031 (USD MILLION) 225
TABLE 190 EUROPE: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024?2031 (USD MILLION) 226
TABLE 191 ASIA PACIFIC: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024?2031 (USD MILLION) 226
TABLE 192 LATIN AMERICA: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024?2031 (USD MILLION) 227
TABLE 193 MIDDLE EAST: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024?2031 (USD MILLION) 227
TABLE 194 GCC COUNTRIES: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY,
2024?2031 (USD MILLION) 227
TABLE 195 OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET,
BY REGION, 2024?2031 (USD MILLION) 228
TABLE 196 NORTH AMERICA: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 228
TABLE 197 EUROPE: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 229
TABLE 198 ASIA PACIFIC: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 229
TABLE 199 LATIN AMERICA: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 230
TABLE 200 MIDDLE EAST: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 230
TABLE 201 GCC COUNTRIES: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 230
TABLE 202 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024?2031 (USD MILLION) 231
TABLE 203 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY REGION, 2024?2031 (USD MILLION) 232
TABLE 204 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 232
TABLE 205 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 233
TABLE 206 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 233
TABLE 207 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 234
TABLE 208 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 234
TABLE 209 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 234
TABLE 210 ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY REGION, 2024?2031 (USD MILLION) 235
TABLE 211 NORTH AMERICA: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024?2031 (USD MILLION) 236
TABLE 212 EUROPE: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024?2031 (USD MILLION) 236
TABLE 213 ASIA PACIFIC: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024?2031 (USD MILLION) 237
TABLE 214 LATIN AMERICA: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024?2031 (USD MILLION) 237
TABLE 215 MIDDLE EAST: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024?2031 (USD MILLION) 238
TABLE 216 GCC COUNTRIES: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024?2031 (USD MILLION) 238
TABLE 217 OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024?2031 (USD MILLION) 239
TABLE 218 NORTH AMERICA: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 239
TABLE 219 EUROPE: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 240
TABLE 220 ASIA PACIFIC: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 240
TABLE 221 LATIN AMERICA: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 241
TABLE 222 MIDDLE EAST: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 241
TABLE 223 GCC COUNTRIES: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 241
TABLE 224 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY REGION, 2024?2031 (USD MILLION) 242
TABLE 225 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 243
TABLE 226 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 243
TABLE 227 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 244
TABLE 228 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 244
TABLE 229 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 245
TABLE 230 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 245
TABLE 231 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024?2031 (USD MILLION) 246
TABLE 232 PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY REGION, 2024?2031 (USD MILLION) 246
TABLE 233 NORTH AMERICA: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY,
2024?2031 (USD MILLION) 247
TABLE 234 EUROPE: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY,
2024?2031 (USD MILLION) 247
TABLE 235 ASIA PACIFIC: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY,
2024?2031 (USD MILLION) 248
TABLE 236 LATIN AMERICA: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY,
2024?2031 (USD MILLION) 248
TABLE 237 MIDDLE EAST: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY,
2024?2031 (USD MILLION) 249
TABLE 238 GCC COUNTRIES: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY,
2024?2031 (USD MILLION) 249
TABLE 239 OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET,
BY REGION, 2024?2031 (USD MILLION) 250
TABLE 240 NORTH AMERICA: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 250
TABLE 241 EUROPE: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 251
TABLE 242 ASIA PACIFIC: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 251
TABLE 243 LATIN AMERICA: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 252
TABLE 244 MIDDLE EAST: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 252
TABLE 245 GCC COUNTRIES: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 252
TABLE 246 PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2024?2031 (USD MILLION) 253
TABLE 247 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 254
TABLE 248 EUROPE: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 254
TABLE 249 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 255
TABLE 250 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 255
TABLE 251 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 255
TABLE 252 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024?2031 (USD MILLION) 256
TABLE 253 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2024?2031 (USD MILLION) 258
TABLE 254 PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024?2031 (USD MILLION) 259
TABLE 255 PROTEOMICS MARKET FOR SPECTROSCOPY, BY REGION,
2024?2031 (USD MILLION) 259
TABLE 256 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024?2031 (USD MILLION) 260
TABLE 257 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2024?2031 (USD MILLION) 260
TABLE 258 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2024?2031 (USD MILLION) 261
TABLE 259 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024?2031 (USD MILLION) 261
TABLE 260 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2024?2031 (USD MILLION) 262
TABLE 261 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024?2031 (USD MILLION) 262
TABLE 262 MASS SPECTROMETRY MARKET, BY REGION, 2024?2031 (USD MILLION) 263
TABLE 263 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 264
TABLE 264 EUROPE: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 264
TABLE 265 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 265
TABLE 266 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 265
TABLE 267 MIDDLE EAST: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 265
TABLE 268 GCC COUNTRIES: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 266
TABLE 269 NMR SPECTROSCOPY MARKET, BY REGION, 2024?2031 (USD MILLION) 267
TABLE 270 NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 267
TABLE 271 EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 268
TABLE 272 ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 268
TABLE 273 LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 269
TABLE 274 MIDDLE EAST: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 269
TABLE 275 GCC COUNTRIES: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 269
TABLE 276 CD SPECTROSCOPY MARKET, BY REGION, 2024?2031 (USD MILLION) 270
TABLE 277 NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 271
TABLE 278 EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 271
TABLE 279 ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 272
TABLE 280 LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 272
TABLE 281 MIDDLE EAST: CD SPECTROSCOPY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 272
TABLE 282 GCC COUNTRIES: CD SPECTROSCOPY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 273
TABLE 283 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2024?2031 (USD MILLION) 273
TABLE 284 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY REGION,
2024?2031 (USD MILLION) 274
TABLE 285 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024?2031 (USD MILLION) 274TABLE 286 EUROPE: PROTEOMICS MARKET FOR CHROMATOG